Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...

Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development ...

Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 ("INTEGRA") study at the 2025 ...

Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on ...

The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

A study presented at CROI 2025 reveals that a single-question self-efficacy measure effectively predicts ART adherence and viral load suppression among pregnant women with HIV in Malawi, offering a ...

Doctors, clinical officers, nurses, laboratory technologists, pharmacists, community health workers and staff funded by the US Government have been impacted. Service Disruptions: Some facilities ...

Donald Trump’s 1987 bestseller, Trump: The Art of the Deal, includes this memory from when he was in elementary school: “I ...

Up to 80 percent of Uganda’s HIV/Aids response is funded by external donors such as the US government and the Global Fund. The funds have been covering majorly the purchase of antiretroviral drugs and ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...